最新报道:Biopharmaceutical company Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announced today that its Board of Directors has approved a digital asset management strategy as part of its new financial investment policy and capital allocation plan. To this end, the Board has established a Cryptocurrency Committee, which will be responsible for evaluating and, where appropriate, overseeing the implementation of any cryptocurrency investment-related activities, including the potential allocation of up to 50% of the company's cash reserves, currently approximately $10 million, to purchase digital assets.